Neurocrine Bioscience buy Royal Bank of Canada
Start price
05.09.25
/
50%
€123.05
Target price
05.09.26
€127.74
Performance (%)
-5.16%
Price
09.01.26
€116.70
Summary
This prediction is currently active. With a performance of -5.16%, the BUY prediction for Neurocrine Bioscience by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 05.09.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.750% | -2.750% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Royal Bank Of Canada from $144.00 to $149.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€137.35
08.12.25
08.12.25
€154.48
08.12.26
08.12.26
-15.03%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€137.36
29.10.26
29.10.26
-0.98%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
3.78%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
7.21%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
10.20%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
39.96%
09.01.26
09.01.26